Joe Bernardo Joins Linden
Chicago, Illinois (January 2, 2018) – Linden Capital Partners, a Chicago-based private equity firm focused exclusively on healthcare, today announced that Joe Bernardo joined the firm as an Operating Partner. Mr. Bernardo will serve as the Chairman of SeraCare and the lead Operating Partner supporting Linden’s diagnostics and life science tools efforts. Mr. Bernardo most recently served as the President of the Next-Generation Sequencing and Oncology division at Thermo Fisher Scientific.
Mr. Bernardo is a veteran diagnostics executive who spent over 25 years with premier diagnostics organizations such as Thermo Fisher Scientific, Siemens Healthcare, and Abbott Laboratories. He took on the role of President of the Next-Generation Sequencing and Oncology division in 2015 and was responsible for leading Thermo Fisher’s efforts in these businesses, as well as his team which supported the development of innovative NGS-based solutions for other businesses within Thermo Fisher Scientific. Since 2008, Mr. Bernardo held four President positions with Thermo Fisher Scientific, including Next-Generation Sequencing, ImmunoDiagnostics (Phadia), Anatomic Pathology, and Fisher Healthcare. Prior to joining Thermo Fisher, Joe served as the Senior Vice President of the Central Lab Business Unit at Siemens Healthcare. Mr. Bernardo has significant M&A experience and was involved with over 25 due diligences, acquisitions, and integrations since the start of his career.
Mr. Bernardo holds a Bachelor of Science in Chemistry from Lafayette College and a Master of Arts in Chemistry from the University of Virginia. He currently is a Senior Advisor to The Boston Consulting Group.
“After spending my career with Thermo Fisher, Siemens, and Abbott, I am excited to partner with a healthcare exclusive private equity firm that respects and values my management, operational, R&D, and M&A experience in the diagnostics industry,” said Mr. Bernardo.
“Joe has a plethora of relevant experience and brings an unparalleled knowledge base in the diagnostics arena,” said Brian Miller, Managing Partner at Linden. “We are thrilled for him to join SeraCare as Chairman and continue to build upon Linden’s expertise in diagnostics.”
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com